Summit Therapeutics Share Discussion Threads

[luminoso] 05/10/2016 15:39

Realise that and totally agree loads of imminent news, waterloo.
Just seemed that the recent news was worth more than a 4 dollar or 15% upgrade !
As you say, they must have been a bit high in their initial target, considering we had no funding and no deal on the table.
Edit. Have our new friends deserted us ?

[waterloo01] 05/10/2016 14:36

12 month targets luminoso, not where it might end up. They were also at the top end to begin with. Watch them raise it again after we get more detail on RDZ partnerships. Glyn refused to talk much about it as it was about the SRPT tie up, but there is a key event at the end of this month and trial results due and discussions that are now 9 months old, so they will be close to announcing next steps IMO

Edit: US trader talk. They can't find any shares to short! Guess most have found safer hands rather than flippers?

[luminoso] 05/10/2016 14:29

Wainwright only raised from 26 to 30 after this news ? Conservative or what.

[waterloo01] 05/10/2016 14:05

More broker upgrades. Canaccord $14 - $28. Needham now $30 same as Wainwright. (Note there were many more brokers on the call so expect some others too)

I'm fairly sure the deal will include Beckers as it is for the drug and follow on drugs. Regardless if it helps Becker, it's a massive boost to milestones, ultimate royalties and our US territory.

Looking forward to more detail broker notes as to potential revenues on all the above (and RDZ!)

[freedosh] 05/10/2016 13:21

O/T
Im also so glad Hyper that the pension is perking up
Not sure when I will be back in NB but look forward to seeing you again when I am
Did you know that our Chairman also has a home there? Bumped into him at a Fringe by the Sea event
Best wishes

[algernon2] 05/10/2016 13:11

Thanks Freedosh.
I just sent an email to clarify also with Summit so will post when a reply arrives.
Hyper Al, I am also glad you are not heading into quite such a penurious retirement.
Re Nasdaq later:here's to a bounce and no dead cats.
Algernon

[freedosh] 05/10/2016 13:04

Not certain but I see the deal as being for the drug family but other indications are a well established route in the industry.
I am sure Glyn will clarify.

Waiting for a bounce on NASDAQ if Waterloo is correct about the shorting activity at $18 - 19

[algernon2] 05/10/2016 12:50

Your thoughts please:

The agreement seems to be for DMD.
There appears no mention of Beckers.
In the talk yesterday Glyn revealed the Becker community constitutes as large a base as the DMD boys.
He also mentioned the possible near start of trials for Beckers in a passing comment.
Does this mean we could have another deal for the Beckers or go ahead with that group on our own?
As it is equally as large as the Dmd group also according to Glyn could this be a possible second bite of the cherry in the not too distant future, or does Beckers come in as a subset of DMD so would be covered by this agreement in place with Sarepta?.
Freedosh?
Anyone.

[freedosh] 05/10/2016 12:12

Agree. No press release allowed until after the presentation

[waterloo01] 05/10/2016 12:10

They present tomorrow (Dame Kay et al) so if anything new, RNS tomorrow.

[chrisatrdg] 05/10/2016 11:26

My thoughts on C-Diff, having looked at the documentation yesterday including the SEC schedule, tells me that it is likely a good % of resources including that of Glyn must have been on the DMD deal.The DMD deal was their pathway to not needing to go for a further fund raise that we all thought C-diff would replace.C-Diff may therefore have been put on the back burner or was just ticking over but when deal completed will result in another tick up in share price

Tweeted Glyn last night who was at this weeks conference who was with Dame Davies as follows -

'Well done Glyn on the deal of the century for the DMD community.Regards Chris Morton Reading.

He replied as follows -

'Thanks Chris, exciting times.'

I rest my case expect RNS at 12.00 today on this weeks conference.

Edit: Presentations are Thursday afternoon US time.

[luminoso] 05/10/2016 10:58

Sensible thing to do, chrisatrdg, as it sounded like you were pretty heavily exposed. I don't think I have enough so am holding on to the lot. I was caught with cash in hand waiting for a discounted placing that never came. Still, a nice problem to have.

[sorrento06] 05/10/2016 10:35

Does that mean no c-diff deal?

[hugus maximus] 05/10/2016 09:35

That's a great piece of important detail Hyper Al & tightfist

[chrisatrdg] 05/10/2016 09:31

I sold 11.33% of holdings yesterday at an average of £2.41 at a return of 83.70% but for me it is now time to HOLD during this tree shake & wait post US conference today & C-Diff deal then expect share price to go to £3.

Had a small investment in Sareum which went the same way Summit is today so nothing surprises me anymore but still good return but still holding for next increase.

[tightfist] 05/10/2016 09:23

Thanks for that Hyper Al, as the (current) minnow in this new relationship I find those protections quite reassuring. (The man in the cellar, as Hugus put it, is locked in that cellar for quite some time whilst value is hopefully being added upstairs!).What we now need to see is some substance underlying the headline cashflow declaration that all is funded by the upfront $62m payment until end 2018. Cheers, tightfist

[joosepi] 05/10/2016 08:50

Thanks phowdo

[phowdo] 05/10/2016 08:43

You need to divide that £11.37 by 5, as each Nasdaq share is 5 of ours.

[tsmith2] 05/10/2016 08:42

Looking at share price movement in run...leaky?

[joosepi] 05/10/2016 08:41

luminoso where are you getting your prices from? the US price is as follows:
Summit Therapeutics PLC (ADR)
NASDAQ: SMMT - Oct 4, 7:56 PM EDT
14.35USDPrice increase5.70 (65.90%)
After-hours: 14.45Price increase0.70%

14.45 $ at 1.27 = £11.37

[tightfist] 05/10/2016 08:37

This is now at an attractive point for those with modest holdings to chase their profits and add to their positions, IMO.